Back

Live Q&A: NOACs in patients with atrial fibrillation and comorbidities.

28 August 2021 (11:47 - 12:00)
Organised by:
Congress Presentation Part of: Roundtable discussion: NOACs in patients with atrial fibrillation and comorbidities Stroke Prevention Open Access ESC Congress 2021 - The Digital Experience

About the speakers

Photo
Doctor Jonathan Halperin

Mount Sinai Medical Center, New York (United States of America)

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Photo
Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

1 More presentation in this session

Presentation thumbnail
Roundtable discussion: NOACs in patients with atrial fibrillation and comorbidities.
Doctor J. Halperin (New York, US) Professor G. Lip (Liverpool, GB) Doctor J. Eikelboom (Hamilton, CA)
Video

Access the full session

Session thumbnail
Roundtable discussion: NOACs in patients with atrial fibrillation and comorbidities
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 11:47 CET
You may be interested in
thumbnail
Webinar
Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty
10 November 2025
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Congress Presentation
Audience participation.
26 August 2022
thumbnail
Congress Presentation
Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources